PL1904060T3 - Zastosowanie pochodnych ftalocyjaniny do nie-fotodynamicznego leczenia chorób - Google Patents

Zastosowanie pochodnych ftalocyjaniny do nie-fotodynamicznego leczenia chorób

Info

Publication number
PL1904060T3
PL1904060T3 PL06777523T PL06777523T PL1904060T3 PL 1904060 T3 PL1904060 T3 PL 1904060T3 PL 06777523 T PL06777523 T PL 06777523T PL 06777523 T PL06777523 T PL 06777523T PL 1904060 T3 PL1904060 T3 PL 1904060T3
Authority
PL
Poland
Prior art keywords
diseases
photodynamic treatment
phthalocyanine derivates
derivates
phthalocyanine
Prior art date
Application number
PL06777523T
Other languages
English (en)
Inventor
Gabrio Roncucci
Lia Fantetti
Giacomo Chiti
Donata Dei
Carmela Alongi
Annalisa Cocchi
Original Assignee
Molteni Therapeutics S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITFI20060090 external-priority patent/ITFI20060090A1/it
Application filed by Molteni Therapeutics S R L filed Critical Molteni Therapeutics S R L
Publication of PL1904060T3 publication Critical patent/PL1904060T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/315Zinc compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL06777523T 2005-06-29 2006-06-29 Zastosowanie pochodnych ftalocyjaniny do nie-fotodynamicznego leczenia chorób PL1904060T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US69575205P 2005-06-29 2005-06-29
ITFI20060090 ITFI20060090A1 (it) 2006-04-04 2006-04-04 Uso di derivati ftalocianinici per la preparazione di composizioni farmaceutiche
EP06777523A EP1904060B1 (en) 2005-06-29 2006-06-29 Use of phthalocyanine derivates for the non-photodynamic treatment of diseases
PCT/EP2006/063698 WO2007000473A1 (en) 2005-06-29 2006-06-29 Use of phthalocyanine derivates for the non-photodynamic treatment of diseases

Publications (1)

Publication Number Publication Date
PL1904060T3 true PL1904060T3 (pl) 2011-12-30

Family

ID=37074204

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06777523T PL1904060T3 (pl) 2005-06-29 2006-06-29 Zastosowanie pochodnych ftalocyjaniny do nie-fotodynamicznego leczenia chorób

Country Status (3)

Country Link
EP (1) EP1904060B1 (pl)
PL (1) PL1904060T3 (pl)
WO (1) WO2007000473A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2375090C1 (ru) * 2008-07-21 2009-12-10 Федеральное государственное унитарное предприятие "Государственный научный центр "Научно-исследовательский институт органических полупродуктов и красителей" (ФГУП "ГНЦ "НИОПИК") Способ подавления опухолевого роста
RU2411049C1 (ru) * 2009-05-29 2011-02-10 Государственное унитарное предприятие г. Москвы "Международный научный и клинический центр "Интермедбиофизхим" (ГУП "МНКЦ "Интермедбиофизхим") Способ лечения больных псориазом
IT1395907B1 (it) * 2009-07-30 2012-11-02 Molteni E C Dei Flii Alitti Societa Di Esercizio Spa L Derivato ftalocianinico costituito da una miscela di quattro isomeri
FI127163B (en) 2016-11-17 2017-12-29 Tty-Säätiö photosensitizer
EP3553062A1 (en) * 2018-04-09 2019-10-16 Chemical Intelligence Limited Antimicrobial and anticancer cationic phthalocyanine compounds
US20220386724A1 (en) * 2019-07-01 2022-12-08 Chemical Intelligence Limited Antimicrobial dyes for healthcare apparel
CN113018500B (zh) * 2021-03-10 2022-04-12 西华师范大学 一种协同化学和光动力抗菌抗病毒涂层及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5109016A (en) * 1988-05-23 1992-04-28 Georgia State University Foundation, Inc. Method for inhibiting infection or replication of human immunodeficiency virus with porphyrin and phthalocyanine antiviral compositions
JP3830993B2 (ja) * 1995-08-23 2006-10-11 株式会社興人 水溶性金属フタロシアニン誘導体を担持した消臭抗菌材
CA2283057A1 (en) * 1997-02-05 1998-08-06 Board Of Regents, The University Of Texas System Porphyrin compounds as telomerase inhibitors
IT1294325B1 (it) * 1997-08-14 1999-03-24 Molteni L E C Dei Fratelli Ali Zinco-ftalocianine e relativi coniugati, preparazione e uso nella terapia fotodinamica e come diagnostici
ATE259814T1 (de) * 2000-06-15 2004-03-15 Molteni & C Substituierte metallphthalocyaninen, ihre herstellung und verwendung
DE60205085T2 (de) * 2002-04-25 2006-04-20 L. Molteni & C. dei Fratelli Alitti Società di Esercizio S.p.A. Metallphthalocyanin-analoge enthaltende antibakterielle Zusammensetzungen

Also Published As

Publication number Publication date
WO2007000473A1 (en) 2007-01-04
EP1904060A1 (en) 2008-04-02
EP1904060B1 (en) 2011-06-01

Similar Documents

Publication Publication Date Title
IL187168A0 (en) Improved nanobodiestm for the treatment of aggregation-mediated disorders
IL227841A0 (en) Dihydropyridinones for the treatment of cancer
IL191832A0 (en) Pyridiazinone derivatives for the treatment of tumours
IL184934A0 (en) 4-oxoquinazoline-3-yl-benzamide derivatives for the treatment of cytokine diseases
IL176629A0 (en) Sulfonamide derivatives for the treatment of diseases
AP2006003669A0 (en) Sulfonamide derivatives for the treatment of diseases
IL187715A0 (en) Use of phenylsemicarbazones for seed treatment
PL1890705T3 (pl) Zastosowanie 24-nor-UDCA do leczenia cholestatycznych chorób wątroby
GB0523961D0 (en) The treatment of ophthalmic diseases
PL1904060T3 (pl) Zastosowanie pochodnych ftalocyjaniny do nie-fotodynamicznego leczenia chorób
GB0400802D0 (en) Compounds for the treatment of disease
IL187792A0 (en) 4-anilino-3-quinolinecarbonitriles for the treatment of cancer
GB0517387D0 (en) Combinations for the treatment of cancer
ZA200805522B (en) Dioxoiane dérivates for the treatment of cancer
GB0523964D0 (en) The treatment of ophthalmic diseases
EP1865952A4 (en) COMPOSITIONS CONTAINING HISTAMINES FOR THE TREATMENT OF ALLERGIES
ZA200800393B (en) Use of phenylsemicarbazones for seed treatment
GB0502171D0 (en) Well treatment
GB0519274D0 (en) The treatment of neurodegenerative diseases
ZA200606780B (en) Compounds for the treatment of diseases
GB0523962D0 (en) The treatment of ophthalmic diseases
GB0523965D0 (en) The treatment of ophthalmic diseases
GB0425054D0 (en) Formamide derivatives for the treatment of diseases
GB0423927D0 (en) The treatment of IBD
GB0517386D0 (en) Combinations for the treatment of cancer